Literature DB >> 9629841

Amyloid myopathy: an underdiagnosed entity.

S Spuler1, A Emslie-Smith, A G Engel.   

Abstract

Amyloidosis can involve multiple organs, including kidney, heart, peripheral nerve, skin, joints, and skeletal muscle, but rarely presents as a myopathy. We studied 13 adults with muscle weakness for between 3 months and 4 years in whom the diagnosis of systemic amyloidosis was unsuspected before or until just before the time of the muscle biopsy. All muscle specimens demonstrated congophilic deposits around blood vessels and muscle fibers, some necrotic and regenerating fibers, and signs of mild denervation. Immunostains in 10 patients revealed immunoglobulin amyloidosis in 7 and gelsolin amyloidosis in 1. Apolipoprotein E co-localized with the congophilic deposits in all 10, and a C-terminal epitope of the beta-amyloid precursor protein was detected in 6. The frequency of the diagnosis of amyloid myopathy increased 10-fold when we adopted the fluorescent Congo red stain as a routine procedure in assessing muscle biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629841     DOI: 10.1002/ana.410430606

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

Review 1.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

2.  Isolated myopathy as the initial manifestation of primary systemic amyloidosis.

Authors:  D Karacostas; M Soumpourou; I Mavromatis; G Karkavelas; I Poulios; I Milonas
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

3.  Amyloid myopathy with external ophthalmoparesis.

Authors:  Akihiko Hoshi; Masahiro Ebitani; Gaku Tanaka; Kouichirou Nakamura; Ken Shibano; Nozomu Matsuda; Masafumi Abe; Yoshikazu Ugawa
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

4.  Amyloid myopathy as the presenting feature of lymphoplasmacytic lymphoma.

Authors:  Zain Guduru; Abhishek Purohit; Cunfeng Pu; Sandeep Rana
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

5.  Amyloid myopathy: a therapeutic trial for the rare and underdiagnosed myopathy with bortezomib.

Authors:  Kensuke Shiga; Reiko Mizutani; Reina Isayama; Chihiro Shimazaki; Takahiko Tokuda; Masanori Nakagawa
Journal:  J Neurol       Date:  2010-07-08       Impact factor: 4.849

6.  Multiple myeloma-associated iliopsoas muscular amyloidoma first presenting with bilateral femoral nerve entrapment.

Authors:  Xinru Du; Lingxiu Zhao; Wenming Chen; Luan Jiang; Xuewei Zhang
Journal:  Int J Hematol       Date:  2012-04-07       Impact factor: 2.490

7.  Expanding the spectrum of monoclonal light chain deposition disease in muscle.

Authors:  Lyle W Ostrow; Andrea M Corse; Brett M Morrison; Carol A Huff; John A Carrino; Ahmet Hoke; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

8.  Familial amyloidotic polyneuropathy with muscle, vitreous, leptomeningeal, and cardiac involvement: phenotypic, pathological, and MRI description.

Authors:  D K Prashantha; Arun B Taly; Sanjib Sinha; T Chikkabasavaiah Yasha; Narayanappa Gayathri; J M E Kovur; Joy Vijayan
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

9.  [Amyloidosis in muscular dystrophy].

Authors:  M Carl; C Röcken; S Spuler
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

10.  Chronic myopathy due to immunoglobulin light chain amyloidosis.

Authors:  Irini Manoli; Justin Y Kwan; Qian Wang; Elisabeth J Rushing; Maria Tsokos; Andrew E Arai; Warner M Burch; Angela Dispenzieri; Alexandra C McPherron; William A Gahl
Journal:  Mol Genet Metab       Date:  2013-02-04       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.